Opinion|Videos|December 22, 2025
Current Treatment Guidelines for Schizophrenia
Panelists discuss how evidence-based, patient-tailored guideline adherence enhances long-term schizophrenia outcomes.
Advertisement
Episodes in this series
Panelists discuss how the latest APA guidelines advocate a multimodal approach combining pharmacologic treatment with psychosocial interventions such as cognitive-behavioral therapy and supported employment.
Panelists discuss how adherence, monitoring of adverse effects, and collaborative care are emphasized as pillars of sustained stability. Clinicians are encouraged to adapt evidence-based strategies to individual patient profiles.
Panelists discuss how guideline adherence improves outcomes, but flexibility is required to tailor interventions to patients’ unique needs, comorbidities, and cultural contexts.
Advertisement
Related to this article
Merck has begun the phase 3 ENHANCE-3 trial testing whether ensifentrine added to standard of care prevents COPD exacerbations in high-risk adults.
Non-CF bronchiectasis prevalence rose across commercial, Medicare, and Medicaid plans from 2016 to 2024, while incidence stayed relatively stable.
Shorter telomere length was linked to a usual interstitial pneumonia pattern (UIP) on CT in patients with ILD, per research presented at CHEST 2026.
Low awareness that fatty liver can silently progress and that MASH fibrosis is treatable drives missed follow-up testing, says Rohit Loomba, MD.
The FDA approved asundexian (Sunharbo) with antiplatelet therapy to reduce recurrent stroke risk after noncardioembolic stroke or high-risk TIA.
The FDA granted accelerated approval to amivantamab and hyaluronidase for previously treated recurrent or metastatic head and neck cancer.
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Durvalumab Plus EV Before Surgery in Cisplatin-Ineligible MIBC
2
5 Things to Know About Diabetes-Related Eye Disease Awareness Month
3
ObesityWeek 2026: Studies Map GLP-1 Access Gaps, Obesity's Costs
4
Payers, Eosinophil Thresholds Shape Who Gets a COPD Biologic
5